The trading price of Regulus Therapeutics Inc (NASDAQ:RGLS) closed higher on Tuesday, May 27, and closing at $7.91, 0.25% higher than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $8.20 and a 52-week low
Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $7.87 on Friday, May 16 with a rise of 0.25% from its closing price on previous day. Considering stock’s 52-week price range provides that RGLS hit a high price of $8.20 and saw its price falling to
Regulus Therapeutics Inc (NASDAQ:RGLS) traded at $7.84 at close of the session on Tuesday, May 13 and made a downward move of -0.38% on its previous day’s price. Regulus Therapeutics Inc has a market cap of $542.79 million and is expected to release its quarterly
The trading price of Regulus Therapeutics Inc (NASDAQ:RGLS) remained unchanged on Monday, May 05, and closing at $7.85. In examining the 52-week price action we see that the stock hit a 52-week high of $8.20 and a 52-week low of $0.83. Over the past month,
The trading price of Regulus Therapeutics Inc (NASDAQ:RGLS) remained unchanged on Friday, May 02, and closing at $7.85. Traders who pay close attention to intraday price movement should know that it fluctuated between $7.74 and $7.87. In examining the 52-week price action we see that
Regulus Therapeutics Inc (NASDAQ:RGLS) price closed lower on Tuesday, April 29, and dropping -3.44% below its previous close. A look at the daily price movement shows that the last close reads $3.49, with intraday deals fluctuated between $3.212 and $3.597. The company’s 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $2.76 on Friday, April 25 with a fall of -1.43% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.80 and 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) concluded the trading at $2.76 on Friday, April 25 with a fall of -1.43% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.80 and 5Y monthly beta
Regulus Therapeutics Inc (NASDAQ:RGLS) traded at $2.32 at close of the session on Tuesday, April 22 and made an upward move of 15.42% on its previous day’s price. Looking at the stock we see that its previous close was $2.01 and the beta (5Y monthly)
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.